Stock Insider Ownership (from SEC Form 4)
RDUS / Radius Health, Inc. insiders include MPM Bio IV NVS Strategic Fund LP, MPM BioVentures IV LLC, MPM BIOVENTURES III LLC, MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC, MPM BIOVENTURES III GP L.P., GALAKATOS NICHOLAS, Carmona Jose (Chief Financial Officer), EVNIN LUKE, Fitzpatrick Lorraine A. (Chief Medical Officer), BIOTECH GROWTH N V MPM BIOVENTURES III GMBH & CO. Beteiligungs KG, MPM BIOVENTURES III-QP L.P., Ward Robert (President & CEO), MPM BIOVENTURES III PARALLEL FUND, L.P., Scopa James Paul, Foley Todd, Purandare Dinesh (SVP Global Oncology/Commercial), STEINMETZ MICHAEL, GADICKE ANSBERT, Hattersley Gary (Chief Scientific Officer), KAILIAN VAUGHN M, BB BIOTECH AG, and MPM BIOVENTURES III L.P., SIMON NICHOLAS J III, MPM BioVentures IV GP LLC, HENNER DENNIS, Hoiland Jesper (President and CEO), Harvey Brian Nicholas (Sr. VP and CFO), Snow David P. (Chief Commercial Officer), Graves Kurt, WHEELER KURT, .
Radius Health, Inc. insider trades are found here. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Job titles are listed as of the filing and may not be current. Click the link icon to see the full transaction history.
|Tran Value||Post Value||Percent
BIOTECH GROWTH N V
BB BIOTECH AG
Harvey Brian Nicholas
MPM BioVentures IV LLC
Scopa James Paul
MPM BioVentures IV GP LLC
MPM Bio IV NVS Strategic Fund LP
KAILIAN VAUGHN M
SIMON NICHOLAS J III
MPM BIOVENTURES III LLC
MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC
MPM BIOVENTURES III GMBH & CO. Beteiligungs KG
MPM BIOVENTURES III PARALLEL FUND, L.P.
MPM BIOVENTURES III GP L.P.
MPM BIOVENTURES III L.P.
MPM BIOVENTURES III-QP L.P.
Fitzpatrick Lorraine A.
Snow David P.
- Open market or private purchase of non-derivative or derivative security
- Open market or private sale of non-derivative or derivative security
- Grant, award, or other acquisition of securities from the company (such as an option)
- Conversion of derivative
- Sale or transfer of securities back to the company
- Payment of exercise price or tax liability using portion of securities received from the company
- Gift of securities by or to the insider
- Equity swaps and similar hedging transactions
- Exercise or conversion of derivative security received from the company (such as an option)
- A transaction voluntarily reported on Form 4
- Other (accompanied by a footnote describing the transaction)
Related News Stories
Radius Health, Inc. (RDUS - Free Report) announced that the first patient has been enroled in the phase I study on pipeline candidate, RAD140. (103-1)
The main biotech indices are down slightly on the week in listless trading as the sector consolidates recent gains. (7-2)
We’re going to get started with the next session, which is Radius. Quickly, before we get started, I just need to read a quick disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy at the registration desk. (1-0)
* Radius Health announces pricing of $300 million of 3.00 percent convertible senior notes due 2024
Radius Health, Inc. (RDUS - Free Report) posted a loss of $1.58 per share in the second quarter of 2017, wider than the loss of $1.01 per share in the year-ago quarter and wider than the Zacks Consensus Estimate loss of $1.35. The year-over-year increase in net loss was attributable to an increase in general and administrative expenses.
Good afternoon everyone and welcome to Radius Health's Second Quarter 2017 Results and Business Update. Today’s call is being recorded.
The following slide deck was published by Radius Health, Inc. in conjunction with their 2017 Q2 earnings call.
1h - Asif
16h - Asif